Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 18, 2001

View Archived Issues

Vical and Ichor form collaboration on gene-based delivery of therapeutic proteins

Lexicon grants license to DNA technology for gene targeting

GSK seeks Swedish approval of dutasteride for treatment of BPH

Preclinical studies of Inactine system demonstrate ability to reduce RBC prion proteins

Caspase inhibitor protects myocardium during septic shock by inhibiting myocyte apoptosis

Alizyme highlights product development efforts

European launch of Thyrogen under way

ESICM highlights: pharmacokinetics of drotrecogin alfa determined in PROWESS

InterMune and Boehringer Ingelheim expand partnership to develop product for ovarian cancer

Unigene awarded federal grant to aid in developing hormone for osteoporosis

Amarillo Biosciences receives grant to develop H. pylori vaccine

Further evidence indicating enhanced antiinflammatory activity for NO-releasing steroid

GSK seeks European approval of Seretide for COPD

Strontium ranelate has dual bone formation-enhancing and antiresorptive effects

Positive phase II results reported for methylnaltrexone

FDA grant and European OMP designation for Fibrillex

Mast cell chymase inhibitors discovered at Teijin

Aromatherapy shows no benefit over placebo in postoperative nausea

Cholinergic function modulators claimed for use in nicotine addiction and other disorders by Pfizer

Fujisawa identifies new aminoalcohol beta3-adrenoceptor agonists

Preparation and use of A2A receptor agonists in heart imaging

Intranasal morphine tested for relief of breakthrough pain in cancer patients

FDA clears use of Allergan's Tazorac cream for treatment of acne

Ortho-McNeil patents new series of neuropeptide Y5 receptor ligands

Hydroxamic acid-based inhibitors of sCD23 formation and TNF processing

Patent coverage gained for Gliatech's antiproperdin antibody therapies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...